Policy for administration of intrathecal chemotherapy
exp date isn't null, but text field is
Objectives
Administration of the wrong drug or dose is likely to be fatal.
The following policy has been written to comply with the current national recommendations issued by the Scottish Government “Guidance for the Safe Delivery of Systemic Anti-Cancer Therapy (SACT)” CEL 30 (2012) July 2012 and the current NHSGG&C “Policy for the Prescribing, Supply and Administration of Cytotoxic Intrathecal Systemic Anti-Cancer Therapy.” [Staffnet link]
Scope
Children who require intrathecal chemotherapy.
15/08/2024 This SOP is currently under review. Please contact the Schiehallion On-Call Consultant with any queries pending the update.
Safe Administration of Intrathecal Cytotoxic Chemotherapy – CEL 21 (www.staffnet.ggc.scot.nhs.uk/Acute/Regional%20Services/Specialist%20Oncology%20Services/Pages/SpecialistOncologyChemotherapyServices.aspx - under CEL Guidelines)
Safe and Secure Handling of Medicines in Hospital Wards, Theatres and Departments
(www.ggcprescribing.org.uk/medicines-policies) - under Section 6.2 - Safe and Secure Handling of Medicines (Acute Division)
Policy for the Prescribing, Supply and Administration of Cytotoxic Intrathecal Chemotherapy
(www.staffnet.ggc.scot.nhs.uk/Acute/Regional%20Services/Specialist%20Oncology%20Services/Pages/SpecialistOncologyChemotherapyServices.aspx - under NHSGGC Guidelines)
Last reviewed: 28 August 2023
Next review: 31 August 2025
Author(s): Dr Nick Heaney
Version: 9
Approved By: Schiehallion Clinical Governance Group
Document Id: RHC-HAEM-ONC-013